 |
Rapid proof-of-concept results for early "kill or pursue decisions"
|
|
Incorporation of unique and differentiable product specifications for unparalleled market success
|
|
Control of pharmacodynamics & pharmacokinetics
|
|
Incorporation of additional product functions within generics
|
|
Inclusion of patient subgroups for exact dosing & reduced side effects, e.g. Cytochrome P450 subtypes
|
|
Patient compliance
|
|
Market acceptance & increased market share by a novel dosage form
|
|
Product life-cycle extension
|
|
Removal of barriers toward market entry by prolonged patent protection or new intellectual property
|
